The 20 Best Muscle Invasive Bladder Cancer Doctors Near Me in Rosedale, MD

Dr. Noah Hahn is a medical oncologist in the Baltimore area, caring for patients with bladder cancer. He serves as the deputy director of the Greenberg Bladder Cancer Institute at the Johns Hopkins School of Medicine. Dr. Hahn earned his M.D. from Indiana University School of Medicine. He completed his residency in internal medicine at Duke University School of Medicine and performed a fellowship in medical oncology at Indiana University School of Medicine. Dr. Hahn joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Hahn was the director of the Genitourinary Medical Oncology Program at Indiana University and chief scientific officer for the Hoosier Oncology Group, a cancer research organization that evaluates innovative and promising approaches to cancer treatment. He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer. Dr. Hahn is a member of the Bladder Cancer Task Force for the National Cancer Institute’s Genitourinary Cancer Steering Committee and is chair of the Bladder Cancer Subcommittee of the Eastern Cooperative Oncology Group. Dr. Hahn is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.

Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Bladder Reconstruction, and Nephrectomy. Dr. Hoffman is board certified in American Board Of Internal Medicine.

Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Kates is board certified in American Board Of Urology.

Dr. Satomi Kawamoto is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. She specializes in computed tomography (CT), ultrasound, and image-guided biopsy. Dr. Kawamoto received her M.D. from Gunma University in Gunma, Japan, and subsequently completed two residencies, one in internal medicine at St. Luke’s International Hospital in Tokyo, and a second in diagnostic radiology at Johns Hopkins. She received a postdoctoral fellowship in cross-sectional imaging at Johns Hopkins, and then joined the Johns Hopkins faculty. Dr. Kawamoto’s research focuses on body CT and biopsy, particularly imaging of the genitourinary and gastrointestinal systems. Dr. Kawamoto is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Muscle Invasive Bladder Cancer, Pancreatic Ductal Adenocarcinoma, Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy. Dr. Kawamoto is board certified in American Board Of Radiology.

"Dr. Katarzyna J. Macura is a professor in the Johns Hopkins Medicine department of radiology and radiological science, a professor of oncology and urology at the Johns Hopkins University School of Medicine, and a member of the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Precision Medicine Center of Excellence for Prostate Cancer. She is a radiologist consultant for the Prostate Cancer Multidisciplinary Clinic at The Johns Hopkins Hospital in Baltimore, MD. Dr. Macura established a clinical and research prostate imaging program with a focus on magnetic resonance imaging (MRI). Dr. Macura has expertise in cross-sectional body imaging, MRI and prostate cancer, and image-guided biopsies. Dr. Macura earned her medical degree from the Medical University of Lodz in Poland. She completed a residency in diagnostic radiology at the Medical College of Georgia and a fellowship in cross-sectional body imaging at Johns Hopkins University. Prior to arrival at Hopkins in 2000, Dr. Macura completed post-doctoral research in Artificial Intelligence at the University of Georgia in Athens, GA. With a PhD degree in Medical Informatics, she had pioneered early applications of Artificial Intelligence for medical decision support, a domain that is now rapidly expanding owing to the advancement of computer technologies and recent recognition that decision support augments appropriate utilization of medical technologies, provides second opinion systems for improved diagnostics and management, and allows optimization of medical care delivery with the assessment of quality and safety. Dr. Macura is a certified knowledge engineer. Dr. Macura is a member of several national and international radiology organizations. She served as president of the Maryland Radiological Society, the Maryland Chapter of the American College of Radiology (ACR), between 2013 and 2015, as well as president of the American Association for Women in Radiology (AAWR) in 2005. She was a Chancellor on the ACR Board of Chancellors, serving as the Inaugural Chair of the ACR Commission for Women and Diversity, between 2013 and 2019. She served as Vice-President of the ACR 2019-2020. She was named the Outstanding Teacher of the Year by Hopkins Radiology Residents in 2005 and 2021, and received the Resident Mentoring Awards in 2018 and 2024. Dr. Macura was also named the Honored Educator by the Radiological Society of North America in 2012 and 2014. In 2016, she received the ""Diamond"" Jim Brady Urology Residents teaching award and the AAWR Marie Sklodowska-Curie award. In 2022, she received the Gold Medal from the American College of Radiology. Dr. Macura is a Fellow of the American College of Radiology (FACR), the Society for Advanced Body Imaging (FSABI), and the American Association for Women in Radiology (FAAWR).". Dr. Macura is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Muscle Invasive Bladder Cancer, Fibrolamellar Carcinoma, Renal Cell Carcinoma (RCC), Prostatectomy, and Penectomy. Dr. Macura is board certified in American Board Of Radiology.

Dr. Linda Chi Hang Chu is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Her clinical expertise includes body CT, MRI and US. Her research interests include abdominal imaging, cancer imaging, radiomics, and artificial intelligence. Dr. Chu graduated from the University of Toronto in 2003 and was awarded the Governor General's Silver Medal, the highest academic achievement from the undergraduate program. She earned her medical degree as a member of AOA and phi beta kappa from Johns Hopkins University in Baltimore, MD in 2007. She completed her Diagnostic Radiology residency and body MRI fellowship at Johns Hopkins Hospital. Dr. Chu joined the Johns Hopkins faculty in 2013. Dr. Chu is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Chu is board certified in American Board Of Radiology.

Dr. Atif Zaheer is a Professor of Radiology and Radiological science at Johns Hopkins University School of Medicine, as well as the director of the Cross-Sectional Body Imaging Fellowship program. Dr. Zaheer practices at the Johns Hopkins Hospital in Baltimore, MD. Dr. Zaheer earned his medical degree from the Aga Khan University. He completed a residency in diagnostic radiology at Beth Israel Deaconess Medical Center/Harvard Medical School, followed by a fellowship in abdominal imaging and interventional radiology at Brigham and Women’s Hospital/Harvard Medical School. Dr. Zaheer is also the medical director of the e-Radiology learning program at Johns Hopkins, which provides radiology residents and practicing radiologists around the world with a lecture series designed to address core knowledge of normal anatomy, pathology and background physics required for successful practice of the field. Dr. Zaheer is clinically active in cross-sectional imaging of the body using CT, MRI and Ultrasound and is also involved in multidisciplinary conferences for pancreas, liver and rectal cancer imaging. His research interests include imaging of tumors and inflammatory disorders of the pancreas and is considered a leader in pancreatic imaging. He is the associate editor of the journal Abdominal Radiology and actively participates in clinical trials, publishes scientific articles, authors books on pancreatic and gastrointestinal imaging, and gives talks at national and international conferences. Dr. Zaheer is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Pancreatic Ductal Adenocarcinoma, Pancreas Divisum, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Zaheer is board certified in American Board Of Radiology.

Dr. Edward Wright is an associate professor of urology at the Johns Hopkins School of Medicine. He serves as the Director of Urology at the Johns Hopkins Bayview Medical Center. His clinical and research interests are in male and female urinary incontinence, complex voiding dysfunction and pelvic genitourinary reconstructive surgery. His specialty has less to do with surgical removal and more with mending urological body parts and restoring functionality in them. His passion for Johns Hopkins lies in the fact that it is the type of place where things can be done, and patients’ questions can be answered and solutions to their problems can be found through all of the resources Johns Hopkins has to offer. Dr. Wright earned his M.D. from Dartmouth Medical School in New Hampshire. He completed his residency in urology at The Presbyterian Hospital in the City of New York and performed a fellowship in Urogynecology at Duke University School of Medicine. Dr. Wright is a member of the American Urologic Association and the Mid-Atlantic Section of American Urologic Association as well as the Society for Urodynamics and Female Urology. He has been recognized with a number of awards including Winner of the Urology Chief Resident's debate New York section of the American Urologic Society at the The New York Academy of Medicine. Dr. Wright is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Stress Urinary Incontinence, Urinary Incontinence, Neurogenic Bladder, Osteotomy, and Ureteroscopy. Dr. Wright is board certified in American Board Of Urology.

Dr. Marisa Clifton is the Director of Women’s Health at the Brady Urological Institute. She is fellowship trained. As a leader in the field of female urology, her clinical expertise includes surgical and nonsurgical treatment of pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence, urinary fistulas, genitourinary reconstruction and urethral diverticula. Dr. Clifton is also an Assistant Professor of Urology at the Johns Hopkins School of Medicine and serves as the Director of Robotic Education. In addition, she serves as Vice President of Medical Affairs at Johns Hopkins Bayview Medical Center. She also serves as Associate Chief Medical Officer of The Johns Hopkins Hospital. Her research interests include medical education and clinical outcomes after surgery. Dr. Clifton received her medical degree from the Johns Hopkins University School of Medicine and completed her residency in urology at the Mayo Clinic in Rochester, Minnesota. She completed her fellowship in Female Pelvic Medicine and Reconstructive Surgery at The Cleveland Clinic in Cleveland, Ohio. Dr. Clifton is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Urinary Incontinence, Obstructive Uropathy, Neurogenic Bladder, Sacral Nerve Stimulation, and Hormone Replacement Therapy (HRT). Dr. Clifton is board certified in American Board Of Urology.

Dr. Andrew J. Cohen is an Associate Professor of Urology at Johns Hopkins. He serves as the Division Director of Benign Urology and Director of Advanced Practice Providers at the Johns Hopkins Brady Urological Institute. He has a robust clinical practice focusing on complex genitourinary reconstruction. In particular, he has interest in the management of erectile dysfunction, urinary incontinence, stricture diseases of the urinary system, peyronie's disease, genital skin conditions, buried penis, urinary diversion, and other benign urologic conditions. He has extensive experience in robotic surgery. He also focuses on issues pertinent to cancer survivorship in men. He is well equipped to perform novel minimally invasive procedures such as endoscopic urethroplasty and robotic buccal ureteroplasty. He has an extensive research portfolio, with particular concentration in outcomes and safety research. Dr. Cohen received dual B.S. degrees summa cum laude from the University of Florida in Chemistry and Chemical Engineering, followed by an MD from the University of Chicago where he was inducted into the Alpha Omega Alpha Honor Society. His urologic training was pursued at the University of Chicago. Furthermore, he completed a fellowship in Genitourinary Reconstruction and Trauma at the University of California, San Francisco. Among many honors, he was invited to join the Trauma and Urologic Reconstructive Network of Surgeons in 2025. He was a also a recipient of the 'Rising Star' Award from the Society of Genitouinary Reconstructive Surgeons in 2025. Dr. Cohen is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Urethral Stricture, Hydronephrosis, Obstructive Uropathy, Prostatectomy, and Lithotripsy. Dr. Cohen is board certified in American Board Of Urology.

Dr. Elliot K. Fishman is a Professor in the Johns Hopkins Medicine Department Radiology and Radiological Science, Department of Oncology and Department of Surgery. He serves as a member of the Johns Hopkins Kimmel Cancer Center. His clinical and research interests focus on medical imaging with specific emphasis on three-dimensional (3D) imaging and computed tomography (CT). Dr. Fishman received his B.S. in 1973 and M.D. in 1977 from the University of Maryland. After a residency at Sinai Hospital in Baltimore, he completed a fellowship in CT at Johns Hopkins in 1980 and joined the Johns Hopkins faculty in 1981 as an Assistant Professor. In 1986, he became Associate Professor and, in 1991, Professor of Radiology and Oncology. He is a leader in the development of 3D imaging and rendering, including its impacts on and uses in patient care and management. He was involved from the beginning in the development of 3D imaging through his work with Pixar, which was a spin-off from LucasFilms in San Rafael, California. Over the last 25 years, Dr. Fishman continued to help develop 3D imaging and has been a leader in the development of interactive 3D rendering. His team is consistently at the forefront of research and development of new visualization and post-processing techniques and technologies. Dr. Fishman's extensive body of work in CT has resulted in over 1,000 peer-reviewed publications, and he is the author or co-author of 10 textbooks. He is the recipient of three prestigious Aunt Minnie Awards, honoring his outstanding contributions as both an educator and researcher. In 2007, he was named by Medical Imaging Magazine as the Top Radiologist in the Nation. He is a member of editorial boards for more than 35 journals, an active member of several professional radiology associations and is a past-president of the Society of Body CT/MR. Dr. Fishman is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Angiosarcoma of the Liver, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fishman is board certified in American Board Of Radiology.

Dr. Civelek is a professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. He serves as the director of the Nuclear Medicine Residency Program. Dr. Civelek earned his medical degree at Istanbul University, Istanbul School of Medicine, and completed his residency at Hacettepe University Medical Center, Ankara. He received a scholarship from the International Atomic Energy Agency when he completed his nuclear medicine residency and fellowship at Johns Hopkins in the Division of Nuclear Medicine. After his period as a postdoctoral fellow, he joined Johns Hopkins Medicine as full-time faculty until 2003. In his early years at Johns Hopkins, Dr. Civelek assisted the clinical and research programs. He later served as director of nuclear cardiology and clinical director, the director of Nuclear Medicine Residency Program, as well as medical director of the Nuclear Medicine Technologist Program. Prior to his return to Johns Hopkins, Dr. Civelek was a professor and director of nuclear medicine and PET at the University of Louisville and a professor and director of nuclear medicine at the Saint Louis University Hospital. Dr. Civelek spent two years in the body MRI and MRI-PET section, Department of Radiology and Imaging Sciences, at National Institutes of Health Clinical Center before serving as the deputy chief in their nuclear medicine section. He is a fellow of the American College of Nuclear Medicine and The American College of Angiology, and is a fellow and founding member of the American Society of Nuclear Cardiology. Dr. Civelek has trained numerous American and international physicians in nuclear medicine, including nuclear cardiology and nuclear oncology. He has a worldwide reputation in nuclear medicine and lectures at medical centers in the U.S. and internationally on nuclear medicine, including nuclear cardiology and nuclear oncology/PET-CT and PET-MRI. Dr. Civelek is committed to the continued progress of nuclear medicine, cardiology and oncology and the development of new tumor-targeting radiopharmaceuticals for imaging and therapy. He supports high quality clinical trials and patient care and safety. To date, Dr. Civelek has published more than 210 peer-reviewed manuscripts and abstracts, and he has participated in and fostered many nuclear oncology research projects. He has served on the editorial boards of several journals. He is a reviewer for multiple scientific journals, including the Journal of Nuclear Medicine, American Journal of Radiology, and Journal of Urology. Dr. Civelek is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Prostate Cancer, Lung Cancer, and Familial Prostate Cancer. Dr. Civelek is board certified in American Board Of Nuclear Medicine.

Pamela Johnson is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Johnson is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her clinical expertise encompasses Ampullary Cancer, Liposarcoma, Ureterocele, and Rhabdomyosarcoma Embryonal. Dr. Johnson is board certified in American Board Of Radiology.

Dr. Cheng Ting Lin is an associate professor of radiology and radiological science at the Johns Hopkins University School of Medicine. His expertise is in diagnostic radiology with particular focus on chest and cardiac imaging. Dr. Cheng Ting Lin received his undergraduate degree from Boston University. He graduated from State University of New York at Stony Brook, where he also completed a radiology residency training program. Dr. Lin completed fellowship training in cardiothoracic imaging at University of Maryland Medical Center. His research interest includes lung cancer screening and diagnosis, chronic obstructive pulmonary disease, Interstitial lung disease, pulmonary embolism, and coronary artery disease. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Interstitial Lung Disease, Pulmonary Arteriovenous Fistula, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Lin is board certified in American Board Of Radiology.

Dr. James Facciola is a clinical instructor in the Johns Hopkins Medicine Department of Radiology and Radiological Sciences. He specializes in body magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and image-guided biopsy. Dr. Facciola graduated from the Temple University School of Medicine in 2013. He subsequently completed a preliminary surgical internship at Temple University Hospital in Philadelphia, PA followed by a diagnostic radiology residency at Temple University Hospital. Following residency, he completed a year-long fellowship in cross-sectional imaging at Johns Hopkins. Dr. Facciola’s research has included study of the anatomic changes seen in the male and female pelvis in children with bladder exstrophy. He joins the Johns Hopkins faculty in July 2019. Dr. Facciola is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Exstrophy of the Bladder, Pleural Effusion, and Pancreatic Cancer. Dr. Facciola is board certified in American Board Of Radiology.

Jamshid Danaie is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Danaie is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Collapsed Lung, and Gas Bloat Syndrome. Dr. Danaie is board certified in American Board Of Radiology.

Dr. Sedaghat graduated from the University of Virginia in 2006 and the Johns Hopkins University School of Medicine in 2010. He completed an internal medicine internship at GBMC in 2011 and a radiology residency at Geisinger Medical Center in Pennsylvania in 2015. Dr. Sedaghat also completed a 2-year fellowship in abdominal imaging and intervention at Brigham and Women’s Hospital in Boston from 2015-2017. He is Ultrasound Section Chief in the department of radiology. Dr. Sedaghat is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His clinical expertise encompasses Ascites, Ampullary Cancer, Lymphofollicular Hyperplasia, and Thyroid Nodule. Dr. Sedaghat is board certified in American Board Of Radiology.

Dr. Stefan Loy Zimmerman is a Professor in the Johns Hopkins University School of Medicine in the Departments of Radiology and Medicine (Cardiology). He specializes in cardiothoracic imaging and is the Division Director of Diagnostic Imaging and Director of Cardiac Imaging. He is the program director for the Cardiothoracic Imaging Fellowship in Radiology. Dr. Zimmerman earned his medical degree from the University of Pennsylvania School of Medicine. He completed both a radiology residency and a cardiovascular imaging fellowship at the Hospital of the University of Pennsylvania. His research focuses on the use of CT and MR imaging in the diagnosis and management of cardiovascular diseases. He has particular interest in the use of cardiac imaging for management of arrhythmias, diagnosis and prognosis of arrhythmogenic right and left ventricular cardiomyopathy, and pulmonary hypertension. Dr. Zimmerman is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Supraventricular Tachycardia (PSVT), Rhabdomyosarcoma, Synovial Sarcoma, Cardiac Ablation, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Zimmerman is board certified in American Board Of Radiology.

Stephanie Coquia is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Coquia is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Thyroid Nodule, Tenosynovitis, and Small Bowel Resection.

Stephen Ronson is a Radiation Oncologist practicing medicine in Rosedale, Maryland. Dr. Ronson is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor.